Breast tumour volume and blood flow measured by MRI after one cycle of epirubicin and cyclophosphamide-based neoadjuvant chemotherapy as predictors of pathological response

OBJECTIVES: Better markers of early response to neoadjuvant chemotherapy (NACT) in patients with breast cancer are required to enable the timely identification of non-responders and reduce unnecessary treatment side-effects. Early functional imaging may better predict response to treatment than conv...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevens, William, Farrow, Isabelle M, Georgiou, Leonidas, Hanby, Andrew M, Perren, Timothy J, Windel, Laura M, Wilson, Daniel J, Sharma, Nisha, Dodwell, David, Hughes, Thomas A, Dall, Barbara JG, Buckley, David L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Institute of Radiology. 2021
Materias:
Full Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248209/
https://www.ncbi.nlm.nih.gov/pubmed/34106751
http://dx.doi.org/10.1259/bjr.20201396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248209/
https://www.ncbi.nlm.nih.gov/pubmed/34106751
http://dx.doi.org/10.1259/bjr.20201396

Ejemplares similares